Capital Access Window - Ondine Biomedical Inc.
AIM
30 September 2026
NOTICE
30/09/2026 7:30am
AIM CAPITAL ACCESS WINDOW
ONDINE BIOMEDICAL INC.
At the request of the Company trading on AIM for the under-mentioned securities has been temporarily suspended pursuant to a Capital Access Window from 30/09/2026 7:30am, pending an announcement.
COMMON SHARES OF NO PAR VALUE, FULLY PAID (CDI)
(BNZGQK5) (CA68234M2058)
If you have any queries relating to the above, please contact the Company's nominated adviser on +44 (0)20 7409 3494.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.